FREDUN PHARMACEUTICALS
Back to All Ratios
|
FREDUN PHARMACEUTICALS Last 5 Year Sales/Fixed Asset History
[Consolidated]
| Mar2025 | |
|---|---|
| Sales/Fixed Asset(x) | 5.63 |
What is the latest Sales/Fixed Asset ratio of FREDUN PHARMACEUTICALS ?
| Year | Sales/Fixed Asset |
|---|---|
| Mar2025 | 5.63 |
How is Sales/Fixed Asset of FREDUN PHARMACEUTICALS Trending?
| Years | Sales/Fixed Asset | % Change | |
|---|---|---|---|
| Mar2025 | 5.63 | - | |
Other Financial Ratios of FREDUN PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Sales/Fixed Asset ratio of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,263.8 Cr | -3.3% | -2.8% | 224.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,145.0 Cr | -0.1% | -2.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,989.0 Cr | -0.2% | -2.8% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,322.0 Cr | 2.3% | 1.2% | 41.1% | Stock Analytics | |
| CIPLA | ₹112,149.0 Cr | 0.7% | 1.9% | -4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,483.0 Cr | 0.1% | -2.4% | 2.3% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -3.3% |
-2.8% |
224.2% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses